Charlie Davie is Managing Director of UCLPartners and a practising Consultant Neurologist at the Royal Free London NHS Foundation Trust.
Charlie has played an integral leadership role in UCLPartners since 2009, when he was the Stroke Lead during the reconfiguration of services and establishment of Hyper Acute Stroke Units in London. Charlie subsequently became Programme Director for Neurosciences at UCLPartners, before taking on the role of Managing Director of the Academic Health Science Network from 2014-2019. During this time, Charlie took the AHSN from strength-to-strength and provided strategic direction for high profile initiatives including: NHS Test Beds, NHS Innovation Accelerator and DigitalHealth.London.
Charlie has held a number of important national advisory roles, most recently as a member of the Accelerated Access Review Implementation Group working with the Office of Life Sciences and NHS England, and was a member of Rt Hon George Freeman’s Life Sciences Cabinet.
Charlie has over 30 years’ continuous clinical service in the NHS and is a Fellow of the Royal College of Physicians.
Our Science and Infrastructure Delivery Group
Our Science and Infrastructure Delivery Group’s role is to ensure all areas of the institute are delivering. This includes all aspects of the infrastructure strategy - the DIH programme,...
Delineating the adverse impacts of the COVID-19 pandemic on patients with cancer and cancer services
13 May 2020
HDR UK researchers analysed recent weekly data from major cancer centres in the UK and found a 76% average decrease in urgent referrals from GPs for people with suspected cancers and a 60% average...
New Research highlights risk of 18,000 extra deaths in people with cancer due to the COVID-19 Crisis
29 April 2020
The COVID-19 emergency could result in at least 20% more deaths over the next 12 months in people who have been newly diagnosed with cancer, according to a study involving with a collaboration...